Hoth Therapeutics Statistics
Total Valuation
HOTH has a market cap or net worth of $5.20 million. The enterprise value is -$3.95 million.
| Market Cap | 5.20M |
| Enterprise Value | -3.95M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, after market close.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
HOTH has 4.40 million shares outstanding. The number of shares has increased by 184.69% in one year.
| Shares Outstanding | 4.40M |
| Shares Change (YoY) | +184.69% |
| Shares Change (QoQ) | -2.14% |
| Owned by Insiders (%) | 1.62% |
| Owned by Institutions (%) | 6.98% |
| Float | 3.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.60 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.89, with a Debt / Equity ratio of 0.01.
| Current Ratio | 13.89 |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -76.30% and return on invested capital (ROIC) is -86.72%.
| Return on Equity (ROE) | -76.30% |
| Return on Assets (ROA) | -66.80% |
| Return on Capital (ROIC) | -86.72% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.92M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.15% in the last 52 weeks. The beta is 0.61, so HOTH's price volatility has been lower than the market average.
| Beta (1Y) | 0.61 |
| 52-Week Price Change | -41.15% |
| 50-Day Moving Average | 1.34 |
| 200-Day Moving Average | 1.64 |
| Relative Strength Index (RSI) | 42.76 |
| Average Volume (30 Days) | 450,206 |
Short Selling Information
The latest short interest is 218,064, so 4.95% of the outstanding shares have been sold short.
| Short Interest | 218,064 |
| Short Previous Month | 27,305 |
| Short % of Shares Out | 4.95% |
| Short % of Float | 5.67% |
| Short Ratio (days to cover) | 0.19 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.69M |
| Pretax Income | -7.85M |
| Net Income | -7.85M |
| EBITDA | -7.85M |
| EBIT | -7.85M |
| Earnings Per Share (EPS) | -$2.30 |
Balance Sheet
The company has $9.29 million in cash and $55,165 in debt, giving a net cash position of $9.24 million or $2.10 per share.
| Cash & Cash Equivalents | 9.29M |
| Total Debt | 55,165 |
| Net Cash | 9.24M |
| Net Cash Per Share | $2.10 |
| Equity / Book Value | 8.82M |
| Book Value Per Share | 2.00 |
| Working Capital | 8.75M |
Cash Flow
| Operating Cash Flow | -8.45M |
| Capital Expenditures | n/a |
| Free Cash Flow | -8.45M |
| FCF Per Share | -$2.48 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HOTH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -184.69% |
| Shareholder Yield | -184.69% |
| Earnings Yield | -148.46% |
| FCF Yield | -159.84% |
Analyst Forecast
The average price target for HOTH is $7.50, which is 509.76% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.50 |
| Price Target Difference | 509.76% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 26, 2022. It was a reverse split with a ratio of 1:25.
| Last Split Date | Oct 26, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |